Tag: Canntab Therapeutics
December 23, 2019
Canntab Submits Site Evidence Package to Obtain LP Status
Canntab Therapeutics announced it has submitted its site evidence package to Health Canada for approval of their licence producer status.
August 5, 2019
Cannabis Investment: Canadian Cannabis Stocks
Are you interested in cannabis investment? Here's a list of Canadian marijuana stocks for investors to reference.
July 31, 2019
CSE Marijuana Stocks
More and more marijuana stocks are joining the Canadian Securities Exchange. Here's a breakdown of the companies listed there.
July 24, 2019
US Cannabis Stocks
Canadian companies dominate the global cannabis market, but US cannabis stocks show much potential for savvy investors.
March 4, 2019
Canntab Discusses Hemp Supply Agreement with FSD Pharma and Canada’s Second Wave of Cannabis Legalization
Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) CFO Richard Goldstein was featured in an interview on Midas Letter.
February 28, 2019
Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) (“Canntab” or the “Company”) is pleased to announce that it has entered into a supply and... February 20, 2019